Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.
about
Review of the literature examining the correlation among DNA microarray technologiesThree microarray platforms: an analysis of their concordance in profiling gene expression.Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays.Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms.Toxicogenomics in risk assessment: communicating the challengesProtocols for the assurance of microarray data quality and process control.Recent applications of DNA microarray technology to toxicology and ecotoxicologyGene expression analysis of the hepatotoxicant methapyrilene in primary rat hepatocytes: an interlaboratory study.Integrative biological analysis for neuropsychopharmacologyThe use of toxicogenomic data in risk assessment: a regulatory perspective.Use of transcriptomics in understanding mechanisms of drug-induced toxicityIndependence and reproducibility across microarray platforms.Identification and categorization of liver toxicity markers induced by a related pair of drugs.Toxicogenomics and systems toxicology: aims and prospects.Toxicogenomics: regulatory perspective on current position.Idiosyncratic drug hepatotoxicity.Gene expression profile analysis: an emerging approach to investigate mechanisms of genotoxicity.The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.Large-scale databases in toxicogenomics.The hepatic transcriptome in human liver diseaseCross-species comparative toxicogenomics as an aid to safety assessment.Intrinsic disorder in nuclear hormone receptors.Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.Guidelines for the routine application of the peptide hits technique.Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.Defining best practice for microarray analyses in nutrigenomic studies.Variation in the hepatic gene expression in individual male Fischer rats.
P2860
Q24644133-AA74BE3B-F2F9-4BD6-903E-0E8A8A1E9528Q24810026-6ADE70CF-4229-4C4C-9655-60532C9A8949Q24811499-18CA0C5A-23AA-40DC-8921-B5BAADB51182Q24811528-CD405ACE-16DC-4D66-9194-5952480EDEDCQ24811575-8B3C38AA-8D13-4364-9499-1DC9A0B5F039Q24813447-A6FFDAEA-728F-4CB9-B9A3-587BC3220235Q24815064-916354D3-86B7-446F-8CC7-DC33DBC399BDQ25256581-AA23CBDA-927D-4EE3-8323-9B1093823A17Q25256771-E2139233-6A6E-4E73-8F27-83B591F77ED7Q28392635-F549B993-B55E-4F83-8E1B-443241C164BFQ30986903-27BA0305-285C-4455-AC23-7E0958C73B5DQ33909001-5207A8F7-415F-4F61-BCDB-8B8764395ACFQ34413212-7C44CF0D-FDE6-484B-95F1-48AE0413C12CQ35162180-CF392353-DFDF-4D17-AB12-EE330052BAE2Q35968452-560794F3-2702-43FB-874E-968AB011125AQ36052609-4E9DE0AF-6AE3-43C7-9486-81E07784F3DBQ36148442-29AB0E6D-BCDA-411B-A2FA-A4C065892621Q36186960-C8BFC7E2-4FAE-4419-838C-D32A3DA923FBQ36278011-C2B1B8D5-9C5C-40BF-A664-47E39FBDFE69Q36278022-D82CEFA3-2CC3-4881-94B7-26D30086494DQ36647336-1E119567-B6C1-4D5B-884D-3C50C2EDBBD2Q36662861-EEEE90B8-864C-4A3B-83A4-1BED6FA4503FQ37238407-3ED12D06-553D-4124-B166-0CFAC42CB57AQ37801286-B98AAFAE-C599-40FF-BC82-60809B60F7B0Q40410930-0B782D7C-655D-4A28-9A8A-F5EB42A261B4Q42623676-79841852-96AE-4C7F-B08F-82E8A66FF520Q44438049-19832CA0-5A1C-4B18-A6A2-2F7B25CC3C27Q53620480-BF29095F-7584-41D2-A46A-E373BAF4D506Q53624130-346B94CC-7C14-481C-B738-70FEF2D404DE
P2860
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Overview of an interlaboratory ...... nts on hepatic gene expression
@nl
Overview of an interlaboratory ...... ts on hepatic gene expression.
@ast
Overview of an interlaboratory ...... ts on hepatic gene expression.
@en
type
label
Overview of an interlaboratory ...... nts on hepatic gene expression
@nl
Overview of an interlaboratory ...... ts on hepatic gene expression.
@ast
Overview of an interlaboratory ...... ts on hepatic gene expression.
@en
prefLabel
Overview of an interlaboratory ...... nts on hepatic gene expression
@nl
Overview of an interlaboratory ...... ts on hepatic gene expression.
@ast
Overview of an interlaboratory ...... ts on hepatic gene expression.
@en
P2093
P2860
P356
P1476
Overview of an interlaboratory ...... ts on hepatic gene expression.
@en
P2093
G Gordon Gibson
John C Rockett
Roger G Ulrich
Syril D Pettit
P2860
P304
P356
10.1289/EHP.6675
P407
P577
2004-03-01T00:00:00Z